Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026)
Lemaitre Vascular's (LMAT) quarterly Other Non-Current Liabilities came in at $1.3 million in Q1 2026, up 49.83% year-on-year from $875000.0 in Q1 2025, and down 10.69% on a QoQ basis from $1.5 million in Q4 2025.
Lemaitre Vascular (LMAT) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Other Non-Current Liabilities data on file, last reported at $1.3 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 49.83% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 49.83% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 76.65% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $1.3 million, down from $1.5 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for LMAT reached as high as $2.4 million in Q3 2022 and fell as low as $187000.0 in Q1 2023.
- Historically, Other Non-Current Liabilities has averaged $1.2 million across 5 years, with a median of $933000.0 in 2025.
- Across the five-year window, Other Non-Current Liabilities soared 1668.38% in 2022 and tumbled 87.69% in 2024, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $2.2 million in 2022, then gained by 4.66% to $2.3 million in 2023, then tumbled by 63.36% to $831000.0 in 2024, then surged by 76.65% to $1.5 million in 2025, then slipped by 10.69% to $1.3 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $1.3 million in Q1 2026, $1.5 million in Q4 2025, and $933000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Lemaitre Vascular | 2.22 Bn | 1.86 Bn | 48.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.31 Mn |
| Dec 31, 2025 | 1.47 Mn |
| Sep 30, 2025 | 933,000.00 |
| Jun 30, 2025 | 934,000.00 |
| Mar 31, 2025 | 875,000.00 |
| Dec 31, 2024 | 831,000.00 |
| Sep 30, 2024 | 264,000.00 |
| Jun 30, 2024 | 2.18 Mn |
| Mar 31, 2024 | 594,000.00 |
| Dec 31, 2023 | 2.27 Mn |
| Sep 30, 2023 | 2.15 Mn |
| Jun 30, 2023 | 578,000.00 |
| Mar 31, 2023 | 187,000.00 |
| Dec 31, 2022 | 2.17 Mn |
| Sep 30, 2022 | 2.41 Mn |
| Jun 30, 2022 | 691,000.00 |
| Mar 31, 2022 | 766,000.00 |
| Dec 31, 2021 | 141,000.00 |
| Sep 30, 2021 | 136,000.00 |
| Jun 30, 2021 | 132,000.00 |